Chemomab Therapeutics Ltd.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2016 | — | $-4.6M | $-4.7M |
| FY2017 | — | $-9.4M | $-9.8M |
| FY2018 | — | $-13.0M | $-13.8M |
| FY2019 | — | $27.1M | $-27.1M |
| FY2020 | — | $6.0M | $-6.0M |
| FY2021 | — | $-12.5M | $-12.5M |
| FY2022 | — | $-28.2M | $-27.6M |
| FY2023 | — | $-24.2M | $-24.2M |
| FY2024 | — | $-103.0M | $-13.9M |
| FY2025 | — | $-112.0M | $-9.0M |